Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,321,459 papers from all fields of science
Search
Sign In
Create Free Account
OIC-A006
Known as:
osteogenic inducible compound-active 006
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Amines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Probleme mit der Opioidtherapie vermeidbar
Dr. Andreas Häckel
Schmerzmedizin
2017
Corpus ID: 43104474
— Bis zu 90 % aller Krebspatienten leiden in fortgeschrittenen Krankheitsstadien trotz guter Kontrolle der Dauerschmerzen unter…
Expand
2017
2017
CRPS: Multimodale Therapie so früh wie möglich beginnen
Gudrun Girrbach
Schmerzmedizin
2017
Corpus ID: 20461928
2016
2016
The effects of different amounts of drug microspheres on the vivo and vitro performance of the PLGA/β-TCP scaffold
Liulan Lin
,
Tianjiang Wang
,
Qi Zhou
,
N. Qian
Designed Monomers and Polymers
2016
Corpus ID: 3662886
Abstract OIC-A006 (BMPs osteogenesis compounds), can stimulate bone marrow mesenchymal stem cells ALP, OPN, OC, Cbfal expression…
Expand
2015
2015
Bone regeneration using a freeze-dried 3D gradient-structured scaffold incorporating OIC-A006-loaded PLGA microspheres based on β-TCP/PLGA
Liulan Lin
,
Haitao Gao
,
Yangyang Dong
Journal of Materials Science: Materials in…
2015
Corpus ID: 227044142
AbstractTo reveal the latent capacity of the growth factor-like low-molecular-weight material OIC-A006 in tissue regeneration…
Expand
2008
2008
OIC-A006 promotes osteogenesis in vitro and in vivo.
Ming Cai
,
Xiao-dong Liu
,
+10 authors
L. Deng
Pharmazie
2008
Corpus ID: 21919941
Bone morphogenesis proteins (BMPs) are one of the potent bone-forming factors. However, the safety, utility, and cost…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE